Bloomberg
@business
The first word in business news | Watch Live: | Newsletters: | Podcasts:
Joined April 2009
104 Following 10.5M Followers
City Therapeutics, an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range.
